mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0001 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0003 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0004 |